Compositions and delivery systems for transdermal...

Details Compositions and delivery systems for transdermal... Compositions and delivery systems for transdermal...

C - Chemistry, Metallurgy

07

H

C07H 21/00 (2006.01) A61K 31/70 (2006.01) A61K 47/10 (2006.01) A61K 47/48 (2006.01) A61Q 7/00 (2006.01) C12N 15/11 (2006.01)

Patent

CA 2110040

2110040 9221353 PCTABS00017 Neutral Oligomers may be delivered transdermally and across mucous membranes for therapeutic purposes, such as to block expression of a specific target nucleic acid sequence. These neutral Oligomers are useful in treating a variety of pathological conditions, including those of the skin and mucous membranes, as well as conditions effecting other tissues.

Affiliated with

Also associated with

Rating

Compositions and delivery systems for transdermal... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and delivery systems for transdermal..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and delivery systems for transdermal... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1718844